This federal contract award, with ID SPE2DB24D2100|SPE2DB25FBBJZ, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4566770573 - TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $21,568.70, and has an ultimate completion date of January 13, 2025. The award was made on December 19, 2024, and there was no set-aside designation used. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov), and this contract is likely part of the company's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/20/25, 9:53 AM